Temozolomide plus whole brain radiotherapy for the treatment of non-small-cell lung cancer patients with brain metastases: A protocol of an updated systematic review and meta-analysis

INTRODUCTION: Whole brain radiotherapy (WBRT) has been the mainstay treatment of brain metastases (BM) in non-small cell lung cancer (NSCLC) patients for years. Temozolomide (TMZ) could penetrate the blood–brain barrier and some studies showed that TMZ plus MBRT may improve clinical effectiveness. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Hua, Zheng, Shu-Yue, Zhou, Tian, Cui, Hui-Juan, Hu, Kai-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004645/
https://www.ncbi.nlm.nih.gov/pubmed/32000358
http://dx.doi.org/10.1097/MD.0000000000018455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004645/
https://www.ncbi.nlm.nih.gov/pubmed/32000358
http://dx.doi.org/10.1097/MD.0000000000018455

Ejemplares similares